Navigation Links
Ethicon Endo-Surgery Studies Presented at DDW Demonstrate Potential of Pure NOTES Surgery With Company's Toolbox
Date:6/3/2009

CINCINNATI, June 3 /PRNewswire/ -- Ethicon Endo-Surgery, Inc. today announced that multiple studies presented at the 2009 Digestive Disease Week (DDW) demonstrate the company's novel, investigational* Toolbox enables natural orifice translumenal endoscopic surgery (NOTES) procedures without laparoscopic support in porcine models. One of the studies concluded that a new adaptable minimally-invasive surgical platform for NOTES and single-site laparoscopy (SSL) was successfully used to complete a variety of key surgical activities critical to pure natural orifice surgery and SSL.

The seven studies presented at DDW, which involved porcine models and a variety of NOTES procedures, follows 15 studies involving Ethicon Endo-Surgery devices presented in April at the 2009 Society of American Gastrointestinal and Endoscopic Surgeons (SAGES) Annual Meeting. In the coming months, the Ethicon Endo-Surgery Toolbox for natural orifice surgery will be evaluated in a human clinical trial under an investigational device exemption (IDE) from the U.S. Food and Drug Administration (FDA).

"To date, most NOTES procedures performed in humans have been with laparoscopic support. In our study, we found several of the devices in the Ethicon Endo-Surgery Toolbox could successfully be used to address some of the critical visibility and access obstacles present with a pure NOTES approach, warranting further investigation," said Klaus Thaler, M.D., Department of Surgery, University of Missouri Health System.

Investigators of the study entitled, "The Development and Testing of an Adaptable Minimally-Invasive Surgical Platform - The Hydra" found that this surgical platform addressed several challenges with NOTES, including visibility, platform stability and adaptability to be used in multiple interventions and procedures. The surgical platform was used both transgastrically and transvaginally completing multiple key s
'/>"/>

SOURCE Ethicon Endo-Surgery, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Three Independent Studies Include the ImmuKnow(R) Assay to Manage and Optimize Immunosuppression Therapy in Transplant Patients
2. New Preliminary Data from Two Studies Show Clinical Activity of Neratinib in Combination with Trastuzumab and in Combination with Paclitaxel in Advanced HER-2 Positive Breast Cancer
3. VA Studies Advanced Prosthetic Arm
4. PARI Pharmas Nebulized DSCG Shows Results Similar to Inhaled Steroids in Asthma Studies Presented at ATS
5. Results of Two Phase 3 CAPACITY Studies of Pirfenidone in IPF Presented at American Thoracic Society (ATS)
6. AlphaVax Announces Promising Results in Melanoma Studies
7. Autism Studies Presented at Mid-Atlantic Research Consortium Meeting
8. New Studies Show Popular Heartburn Medications Moderate the Effect of Taking Widely Prescribed Heart Drug
9. New Studies on Once-Daily Extended Release Pramipexole Presented at American Academy of Neurology Annual Meeting
10. Affitech-Discovered Anti-PS Antibodies in Development by Peregrine Pharmaceuticals Show Excellent Functionality in Preclinical Studies
11. Studies Presented at AACR Annual Meeting Highlight Multiple Immunomodulatory Mechanisms of Peregrines PS-Targeting Antibodies

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/23/2009)...3/PRNewswire/--TwooftheChicagoarea,sleadingBoardCe...inwomen,sbreastimaging,couplingthelatesttechnology...soundwiththeabilitytohavethefullrangeofdigitalimag...foresheleavestheoffice.Drs.AhmedFaragandJoanWerber...hecurrent6-9monthwaitforanappointmentcommonlyfound...
(Date:11/23/2009)...23/PRNewswire-FirstCall/--NuVasive, Inc. (Nasdaq: ...ductsforminimallydisruptivesurgicaltreatmentsforth...hiefExecutiveOfficer,andMichaelJ.Lambert,Executive...topresentatthe21stAnnualPiperJaffrayHealthCareConf...day,December2,2009,at10:00a.m.ET.Mr.LukianovandMr....
(Date:11/23/2009)...Nov.23/PRNewswire-FirstCall/--Immucor,Inc.(Nasdaq:...t-reagentsystemstothebloodtransfusionindustry,toda...fray21stAnnualHealthCareConferenceinNewYork,NYwill...Company,spresentationisscheduledforTuesday,Decembe...tionwillbeavailablethroughthe"AboutUs--InvestorInf...
Breaking Medicine Technology:NuVasive To Present at the Piper Jaffray Health Care Conference and the J.P. Morgan SMid Cap Conference 2NuVasive To Present at the Piper Jaffray Health Care Conference and the J.P. Morgan SMid Cap Conference 32009 Pharma ChemOutsourcing Show Attendance Up an Astounding 60 25 Despite Current Recession 12440 12009 Pharma ChemOutsourcing Show Attendance Up an Astounding 60 25 Despite Current Recession 12440 2Peregrine Pharmaceuticals Highlights Promising Early Data From Its Three Phase II Bavituximab Cancer Trials 4527 1Peregrine Pharmaceuticals Highlights Promising Early Data From Its Three Phase II Bavituximab Cancer Trials 4527 2Peregrine Pharmaceuticals Highlights Promising Early Data From Its Three Phase II Bavituximab Cancer Trials 4527 3Peregrine Pharmaceuticals Highlights Promising Early Data From Its Three Phase II Bavituximab Cancer Trials 4527 4Peregrine Pharmaceuticals Highlights Promising Early Data From Its Three Phase II Bavituximab Cancer Trials 4527 5Peregrine Pharmaceuticals Highlights Promising Early Data From Its Three Phase II Bavituximab Cancer Trials 4527 6Global Decompression Announces C O D Available on All Used Axiom DRX 9000 Spinal Decompression Systems 47748 1Global Decompression Announces C O D Available on All Used Axiom DRX 9000 Spinal Decompression Systems 47748 2
... Program for Oral Compounds,to Treat Alcohol Depe...2, 2007--Alkermes, Inc.,(Nasdaq: ALKS) today annou...trial of ALKS 29 in alcohol dependent patients. Ba...rward with its,development program for oral produc...is a combination of two agents with distinct,pharm...
...07 -- DOR BioPharma, Inc.,(OTCBB: DORB) ("DOR" or ...lts from testing of a multivalent form of its botu...lished in the journal,Infection and Immunity (Ravi...75, p. 3043 ). These results are the first that,de...valent vaccine,that is active by the mucosal route...
Other Medicine Technology:Alkermes Announces Positive Results from Phase 1/2 Clinical Study,of ALKS 29 2Alkermes Announces Positive Results from Phase 1/2 Clinical Study,of ALKS 29 3Alkermes Announces Positive Results from Phase 1/2 Clinical Study,of ALKS 29 4DOR BioPharma Announces Publication Describing Results of Its,Multivalent Botulinum Toxin Vaccine BT-VACC 2DOR BioPharma Announces Publication Describing Results of Its,Multivalent Botulinum Toxin Vaccine BT-VACC 3DOR BioPharma Announces Publication Describing Results of Its,Multivalent Botulinum Toxin Vaccine BT-VACC 4DOR BioPharma Announces Publication Describing Results of Its,Multivalent Botulinum Toxin Vaccine BT-VACC 5DOR BioPharma Announces Publication Describing Results of Its,Multivalent Botulinum Toxin Vaccine BT-VACC 6
(Date:11/23/2009),, NEWYORK,Nov.23/PRNewswire/--Livingwithchronicpaincanbedifficult-andthestressoftheholidayseasoncanprovetobequitechallengingforthoselivingwithpain. ,, ListentothisreportfromPfizerInc.at: ,
(Date:11/23/2009)...ter suffering from women,s hair loss for almost te...d she,s sharing her progress and the secret behind... the release of her video diaries which include a ...r treatment. , (PRWeb UK)...er Zsanett Siklosi has released the video diaries ...
(Date:11/23/2009)...RNewswire-FirstCall/--InfoLogix,Inc.(Nasdaq: IFLG ...lutionsforthehealthcareandcommercialindustries,ann...ServicesatSiemensHealthServices,hasjoinedInfoLogix..., (Logo: http://www.newscom.com/cgi-bin/prnh/20090...HealthcareServicesforInfoLogix,Mr.Waywillberespons...
(Date:11/23/2009)...atients and survivors treated with chemotherapy su... chronic conditions, hindering patients, ability t...iversity of Rochester Medical Center. , A study ...ep troubles at nearly three times the rate of the ... in younger patients and those with lung and breas...
(Date:11/23/2009)...rop by 63 percent with moderate-to-high intensity ...News) -- Moderate-to-high intensity exercise such ...oke risk in older men but not in women, researcher... and women, average age 69, in Manhattan who were ...here were 238 strokes among the participants. At t...
Breaking Medicine News(10 mins):Health News:Women's Hair Loss Treatment Results Captured on Video to Inspire Others 2Health News:Women's Hair Loss Treatment Results Captured on Video to Inspire Others 3Health News:Jim Way, Former Vice President at Siemens Health Services, Joins InfoLogix, Inc. as Vice President of Strategic Healthcare Services 2Health News:Jim Way, Former Vice President at Siemens Health Services, Joins InfoLogix, Inc. as Vice President of Strategic Healthcare Services 3Health News:Insomnia prevalent among cancer patients who receive chemotherapy 2Health News:Vigorous Exercise Cuts Stroke Risk for Men, Not Women 2
...ts have provided new details about how proteins us...Alzheimer's disease. Gunnar K. Gouras, as... Weill Medical College of Cornell University, New ... for a vaccine against the disease. "Antib...
...alf the central government funds allocated to figh...n southern states that, ironically, were strugglin...ected at least 1.4 million people across the count... help them contain the chikungunya fever. But a su...
...ll establish 30 world-class universities across th...country's entry into the knowledge economy, Prime... "This expansion is going to be a landmark in ...mong the top institutions in the world," the prime...
...must provide more flexible working, the BMA says t... that female doctors embarking on NHS careers outn...t of 435 doctors who graduated from UK medical sch...ed a similar study of medical graduates. This is i...
... with radiation retinopathy who were destined to g... longer through localized treatment with Avastin ,... study published in the June, 2007 Archives of Oph...thy, said Paul T. Finger, MD, lead author of the s...
...iction worldwide appears to be slowing down for al...s Office on Drugs and Crime said on Friday. "...uth of Afghanistan, a cancer that threatens secur.... "Furthermore, progress made in some countrie...
Other Medicine News:Health News:Researchers Link Bacteria Destroying Proteins to Alzheimer's Treatment 2Health News:Researchers Link Bacteria Destroying Proteins to Alzheimer's Treatment 3Health News:Chikungunya Spreads as Funds Remain Unspent 2Health News:India to Have 30 World-class Universities Across the Country: PM 2Health News:BMA Calls for Flexible Working as Number of Women Doctors Swell 2Health News:Untreatable Eye Disease Improves With Avastin 2Health News:Drug Addiction Slowing Down: UN Report 2
Chemstrip Micral
QED A350 Saliva Alcohol Test
AccuSign DOA Series Tests
...highly accurate in detecting the presence of drugs... GC/MS testing. This assay provides a preliminary ...uch as GC/MS) must be used in order to obtain a co...plied to any drug of abuse test result, particular...
Medicine Products: